- Home
- QURE vs KBDC Comparison
QURE vs KBDC Comparison
Compare QURE & KBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QURE | KBDC |
|---|---|---|
| Founded | 1998 | 2021 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 980.7M |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | QURE | KBDC |
|---|---|---|
| Price | $47.51 | $13.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $45.00 | $15.50 |
| AVG Volume (30 Days) | ★ 2.6M | 292.4K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 13.16% |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $126.12 | $193.84 |
| Revenue Next Year | $200.43 | $9.00 |
| P/E Ratio | ★ N/A | $31.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $13.06 |
| 52 Week High | $71.50 | $16.28 |
Technical Indicators
Market Signals| Indicator | QURE | KBDC |
|---|---|---|
| Relative Strength Index (RSI) | 73.18 | 39.37 |
| Support Level | $21.63 | $13.52 |
| Resistance Level | $60.70 | $14.30 |
| Average True Range (ATR) | 2.85 | 0.33 |
| MACD | 1.76 | -0.06 |
| Stochastic Oscillator | 87.87 | 25.18 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About KBDC Kayne Anderson BDC Inc.
Kayne Anderson BDC Inc is an externally managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company, investing mainly in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation mainly through debt investments in middle-market companies.